NasdaqCM - Nasdaq Real Time Price USD

PAVmed Inc. (PAVMZ)

Compare
0.0103
-0.0051
(-33.12%)
At close: January 16 at 1:12:38 PM EST
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
4,034.0000
2,452.0000
377.0000
500.0000
--
Cost of Revenue
6,403.0000
6,420.0000
3,614.0000
585.0000
--
Gross Profit
-2,369.0000
-3,968.0000
-3,237.0000
-85.0000
--
Operating Expense
53,314.0000
64,827.0000
87,850.0000
54,308.0000
23,351.0000
Operating Income
-55,683.0000
-68,795.0000
-91,087.0000
-54,393.0000
-23,351.0000
Net Non Operating Interest Income Expense
292.0000
-84.0000
-1,112.0000
--
-713.0000
Other Income Expense
65,268.0000
-10,384.0000
-11,039.0000
-1,733.0000
-11,824.0000
Pretax Income
9,877.0000
-79,263.0000
-103,238.0000
-56,126.0000
-35,888.0000
Net Income Common Stockholders
14,715.0000
-66,270.0000
-89,264.0000
-50,630.0000
-34,563.0000
Diluted NI Available to Com Stockholders
14,715.0000
-66,270.0000
-89,264.0000
-50,630.0000
-34,563.0000
Total Operating Income as Reported
-55,683.0000
-68,795.0000
-91,087.0000
-54,393.0000
-23,351.0000
Total Expenses
59,717.0000
71,247.0000
91,464.0000
54,893.0000
23,351.0000
Net Income from Continuing & Discontinued Operation
24,324.0000
-64,175.0000
-88,983.0000
-50,347.0000
-34,276.0000
Normalized Income
-39,837.0000
-54,977.0000
-82,276.0000
-48,614.0000
-22,452.0000
Interest Income
349.0000
505.0000
169.0000
--
--
Interest Expense
57.0000
589.0000
1,281.0000
--
53.0000
Net Interest Income
292.0000
-84.0000
-1,112.0000
--
-713.0000
EBIT
9,934.0000
-78,674.0000
-101,957.0000
-56,126.0000
-35,835.0000
EBITDA
11,788.0000
-75,742.0000
-99,500.0000
-55,900.0000
-35,812.0000
Reconciled Cost of Revenue
5,613.0000
5,509.0000
2,941.0000
505.0000
--
Reconciled Depreciation
1,854.0000
2,932.0000
2,457.0000
226.0000
23.0000
Net Income from Continuing Operation Net Minority Interest
24,324.0000
-64,175.0000
-88,983.0000
-50,347.0000
-34,276.0000
Total Unusual Items Excluding Goodwill
64,161.0000
-9,198.0000
-6,707.0000
-1,733.0000
-11,824.0000
Total Unusual Items
64,161.0000
-9,198.0000
-6,707.0000
-1,733.0000
-11,824.0000
Normalized EBITDA
-52,373.0000
-66,544.0000
-92,793.0000
-54,167.0000
-23,988.0000
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers